Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BMS-986446 by Bristol-Myers Squibb for Alzheimer's Disease: Likelihood of Approval
BMS-986446 is under clinical development by Bristol-Myers Squibb and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...